EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Setmelanotide in Bardet‐Biedl Syndrome: A Case Report

Shelby Smith iD, Eric Sanfilippo, Lara Wine Lee iD

Pediatric Dermatology · 2026

DOI: 10.1111/pde.70186 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2026. Verfasst von Shelby Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of South Carolina, Columbia, South Carolina, USA. Hauptthemen laut MEDLINE: alpha-MSH, Bardet-Biedl Syndrome, Hyperpigmentation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Setmelanotide is a melanocortin‐4‐receptor agonist used for the treatment of hyperphagia in the genetic obesity syndrome Bardet‐Biedl. Presented is a case of diffuse hyperpigmentation in a patient treated with setmelanotide, which represents the most common side effect of this medication. Herein is a review of the literature for other potential side effects that warrant regular dermatologic screening, including alteration of existing melanocytic lesions. Exact screening guidelines have not been completely defined, though it is recommended that patients receive baseline and annual examinations while undergoing treatment with this agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-MSHBardet-Biedl SyndromeHyperpigmentationHumansFemaleReceptor, Melanocortin, Type 4

Stichwörter der Autor:innen

Bardet‐Biedl syndromeMCR4 agonistmelanoma risksetmelanotideskin cancer screening

Substanzen

alpha-MSHsetmelanotideReceptor, Melanocortin, Type 4

Autor:innen und Institutionen

  • School of Medicine, University of South Carolina, Columbia, South Carolina, USA.
  • Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA.

ORCID-Profile: Shelby Smith, Lara Wine Lee

Zitieren

APA

Smith, S., Sanfilippo, E., & Lee, L. W. (2026). Setmelanotide in Bardet‐Biedl Syndrome: A Case Report. Pediatric Dermatology. https://doi.org/10.1111/pde.70186

Vancouver

Smith S, Sanfilippo E, Lee LW. Setmelanotide in Bardet‐Biedl Syndrome: A Case Report. Pediatric Dermatology. 2026. doi:10.1111/pde.70186

BibTeX
@article{Smith2026,
  author = {Smith, Shelby and Sanfilippo, Eric and Lee, Lara Wine},
  title = {Setmelanotide in Bardet‐Biedl Syndrome: A Case Report},
  journal = {Pediatric Dermatology},
  year = {2026},
  doi = {10.1111/pde.70186}
}
Kostenlos starten →